We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Brain Cancer

Journal Scan / Research · December 02, 2019

Clinical Utility of Plasma cfDNA in Adults With Newly Diagnosed Glioblastoma

Clinical Cancer Research


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Cancer Research
Clinical Utility of Plasma Cell-Free DNA in Adult Patients With Newly Diagnosed Glioblastoma - A Pilot Prospective Study
Clin. Cancer Res 2019 Oct 30;[EPub Ahead of Print], S Bagley, SA Nabavizadeh, J Mays, JE Till, J Ware, S Levy, W Sarchiapone, J Hussain, TJ Prior, S Guiry, T Christensen, SS Yee, M Nasrallah, JJ Morrissette, Z Binder, DM O'Rourke, AJ Cucchiara, S Brem, AS Desai, EL Carpenter

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading